Origene

Provider and manufacturer of proteins, antibodies, and other molecular tools for research applications

placeRockville, Maryland, United States calendar_todayFounded 1996 groups141 employees language origene.com

Registered entities

Social engagement

Social engagement: 7.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Zero2IPO Ventures, IDG Capital, Cathay Capital, Merieux Developement; 2 have since exited.

Investor typeCountShare
Venture capital640%
Private equity427%
Bank & private debt17%
Other / undisclosed427%

Recent activity

2 Jul 2026
Milestone
regulatory
1 Jul 2026
Product launch
Recombinant human ENO1 (1–434)
26 Jun 2026
Milestone
anniversary
Coming soon